Why Health Care's Future Is All About Value

What the desk is arguing

The desk observes that projected healthcare costs will reach almost 40% of the US federal budget by 2025, influencing both governmental fiscal policies and corporate strategies within the sector. This aligns with insights from Goldman Sachs focused on the industry's pivot towards value-based contracts, which prioritize patient outcomes instead of sheer service volume.

The potential for transformations in economics underscores the importance of this shift for investors and companies alike. Specifically, as these contracts take hold, healthcare delivery costs may stabilize, which should have ripple effects on investments, health outcomes, and by extension, the broader fiscal health of household consumption and disposable income levels.

Where it sits in our coverage

Due to the lack of specific internal coverage data in this instance, we will omit this section entirely.

How other firms see it

Similarly, firms aligned with this value-oriented approach may include those positioned to benefit from cost efficiencies, whereas firms hesitant to fully embrace these changes reflect a more cautious outlook. Such dynamics might lead to divergent strategies across the market.

In the current environment, monitoring healthcare-related equities and related outcomes such as consumer spending growth would be prudent, as these trends typically correlate with healthcare expenditure shifts. Observing the USD-related pairs may yield insights into how these broad economic changes may take shape.